Section 453B.110 - Restrictions on donated cancer drugs1. In addition to the requirements of NRS 453B.080, a donated prescription drug: (a) Must not be a controlled substance.(b) Must not be a compounded drug product.(c) Must not be dispensed by a pharmacist if the pharmacist suspects that the prescription drug is adulterated or misbranded.(d) Must not be dispensed by a pharmacist if, in the professional judgment of the pharmacist, there is a reasonable concern relating to the safety or efficacy of the prescription drug.(e) Must not require refrigeration or freezing or other temperature requirements that are not a controlled room temperature.(f) Must not be a prescription drug for which a program of restrictive distribution has been established by the manufacturer of the prescription drug.(g) Must not be a prescription drug for which an ongoing clinical trial or study is being conducted.(h) Must be a prescription drug that was originally dispensed pursuant to a prescription by a pharmacy licensed pursuant to chapter 639 of NRS.2. As used in this section, "program of restrictive distribution" means a program that is developed in collaboration with the United States Food and Drug Administration by a manufacturer of a drug to reduce the risks associated with that drug by limiting the persons who can prescribe the drug and who can receive the drug.Nev. Admin. Code § 453B.110
Added to NAC by Bd. of Pharmacy by R211-09, eff. 7-22-2010-Substituted in revision for NAC 457.587; A by R007-22A, eff. 12/16/2022NRS 453B.080 and 453B.120